What is the appropriate management for a patient who developed a diffuse rash after receiving cefepime and metronidazole, is now on meropenem, and was given diphenhydramine 1 mL IM and 50 mg PO?

Immediate Management: Stop Meropenem and Assess for Drug Hypersensitivity Reaction

Your patient has developed a diffuse rash while on meropenem after recent exposure to cefepime and metronidazole—you need to immediately discontinue the meropenem and evaluate for a drug hypersensitivity reaction, likely to one of the beta-lactam antibiotics. The diphenhydramine administration was appropriate initial management, but this requires further assessment and potential escalation of therapy.

Critical Assessment Steps

Grade the rash severity immediately:

• Grade 1 (mild/localized): Continue monitoring with antihistamines
• Grade 2 (10-30% body surface area, moderate symptoms): Add topical corticosteroids
• Grade 3 (>30% BSA or substantial symptoms): Requires systemic corticosteroids and drug discontinuation
• Grade 4 (skin sloughing >30% BSA): Medical emergency requiring IV steroids and dermatology consultation 1

Look for warning signs of severe reactions:

• Mucosal involvement (eyes, mouth, genitals)
• Skin sloughing or blistering
• Facial edema or angioedema
• Respiratory symptoms (wheezing, stridor, dyspnea)
• Fever with rash
• Eosinophilia on labs

Antibiotic Culprit Analysis

Most likely culprit: Cefepime or meropenem

The timing and pattern suggest:

• Cefepime causes rash in 1.1-4% of patients, with higher rates at 2g doses 2. Rash was the most common reason for discontinuation in clinical trials (51% of patients who stopped therapy) 2
• Meropenem causes rash in 1.9% of patients 3
• Cross-reactivity concern: While meropenem has low cross-reactivity with penicillins (even in anaphylactic penicillin allergy) 4, there IS potential cross-reactivity between cephalosporins and carbapenems, particularly if the patient had a true hypersensitivity to cefepime 5, 6

Metronidazole is less likely but possible—it can cause hypersensitivity reactions including rash, though this is rare 7, 8

Immediate Treatment Algorithm

For Grade 1-2 rash (most likely scenario):

1. Continue diphenhydramine 25-50 mg PO/IV every 6 hours 9
2. Add topical corticosteroid: Moderate-to-high potency (mometasone 0.1% or betamethasone 0.1% ointment) twice daily 9
3. Discontinue meropenem and switch to non-beta-lactam alternative
4. Monitor closely for 48-72 hours for progression

For Grade 3 rash (>30% BSA or severe symptoms):

1. Systemic corticosteroids: Prednisone 0.5-1 mg/kg PO daily OR methylprednisolone 0.5-1 mg/kg IV if severe 1
2. Continue antihistamines as above
3. Dermatology consultation within 24 hours
4. Permanently discontinue the offending agent

For Grade 4 or signs of Stevens-Johnson Syndrome/TEN:

1. IV methylprednisolone 1-2 mg/kg immediately 1
2. Urgent dermatology consultation
3. ICU-level monitoring
4. Permanent discontinuation of all beta-lactams

Alternative Antibiotic Selection

Safe alternatives (assuming beta-lactam hypersensitivity):

• Fluoroquinolones (levofloxacin, ciprofloxacin) - no cross-reactivity
• Aztreonam - safe in cephalosporin allergy except ceftazidime 10
• Aminoglycosides (gentamicin, tobramycin) - no cross-reactivity
• Vancomycin - no cross-reactivity

Choice depends on infection source and culture data—do NOT empirically restart any beta-lactam until allergy evaluation is complete.

Documentation and Follow-up

Document in allergy list:

• "Cefepime - rash (date)"
• "Meropenem - rash (date)" (if rash developed after starting meropenem)
• Avoid documenting as "penicillin allergy" unless specifically tested

Outpatient allergy testing should be arranged after acute illness resolves to determine:

• True vs. false allergy
• Which specific beta-lactam(s) to avoid
• Safe alternatives for future use

Common Pitfalls

Do not assume this is just a "benign rash"—beta-lactam hypersensitivity can progress rapidly to severe cutaneous adverse reactions (SCAR) including DRESS syndrome, which can develop 2-8 weeks after exposure 11. The combination of fever with rash is particularly concerning.

Do not rechallenge with any beta-lactam during this hospitalization without allergy consultation—cross-reactivity between cephalosporins and carbapenems exists, and the risk of severe reaction increases with re-exposure 10, 5.

Do not rely solely on antihistamines—if the rash is widespread or worsening, systemic corticosteroids are necessary to prevent progression 1.